KDL(SH:603987) Sou Hu Cai Jing·2025-05-20 11:12Group 1 - The core viewpoint of the articles highlights the performance and valuation of Kangdelai, a company in the medical device industry, which has a current PE ratio of 15.12, significantly lower than the industry average of 49.51 [1][2] - As of March 31, 2025, Kangdelai has 25,817 shareholders, a decrease of 822 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] - The company specializes in the research, production, and sales of medical devices, including puncture needles and infusion devices, with its R&D centers recognized at both municipal and provincial levels [1] Group 2 - In the latest quarterly report for Q1 2025, Kangdelai reported a revenue of 548 million yuan, a year-on-year decrease of 3.82%, and a net profit of 60.70 million yuan, with a slight increase of 0.28% [1] - The gross profit margin for the company stands at 32.02%, indicating its profitability in the current market conditions [1] - The company ranks 35th in terms of PE ratio within its industry, reflecting its relative valuation compared to peers [2]